Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.

Adamsick, Meagan L; Gandhi, Ronak G; Bidell, Monique R; Elshaboury, Ramy H; Bhattacharyya, Roby P; Kim, Arthur Y; Nigwekar, Sagar; Rhee, Eugene P; Sise, Meghan E

Adamsick, Meagan L; Gandhi, Ronak G; Bidell, Monique R; Elshaboury, Ramy H; Bhattacharyya, Roby P; Kim, Arthur Y; Nigwekar, Sagar; Rhee, Eugene P; Sise, Meghan E.

Adamsick ML; Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts.
Gandhi RG; Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts.
Bidell MR; Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts.
Elshaboury RH; Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts.
Bhattacharyya RP; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Kim AY; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Nigwekar S; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Rhee EP; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Sise ME; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts msise@partners.org.

J Am Soc Nephrol ; 31(7): 1384-1386, 2020 07.

Article in English | MEDLINE | ID: covidwho-591516

Subject(s)

Acute Kidney Injury/epidemiology; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Cause of Death; Coronavirus Infections/drug therapy; Coronavirus Infections/epidemiology; Kidney Failure, Chronic/epidemiology; Pneumonia, Viral/drug therapy; Pneumonia, Viral/epidemiology; Acute Kidney Injury/diagnosis; Acute Kidney Injury/drug therapy; Adenosine Monophosphate/administration & dosage; Adenosine Monophosphate/adverse effects; Alanine/administration & dosage; Alanine/adverse effects; Antiviral Agents/administration & dosage; Antiviral Agents/adverse effects; COVID-19; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic/diagnosis; Kidney Failure, Chronic/drug therapy; Male; Massachusetts; Pandemics; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate

Keywords

COVID-19; acute renal failure; antiviral; end-stage renal disease

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Adenosine Monophosphate / Cause of Death / Coronavirus Infections / Alanine / Acute Kidney Injury / Kidney Failure, Chronic Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: North America Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google